Guidelines are key to modern health and medical practice. Their recommendations are evidence-based and cover a wide range of topics - managing specific conditions, use of medicines in different settings or services and interventions to improve health.
We are keen to publicise the efforts and outputs of all our guideline Working Groups where we can. Guidelines in Practice
publicise expert content on best clinical practice to primary care health professionals. They recently used our guidelines as an example of their value in‘Accredited guidance promotes excellence in rheumatology’
. Elsewhere, they are also covered the BSR Guideline on tocilizumab in RA
and how it could help practitioners and commissioners
Below are three tables that set out the current status of all of BSR’s guidelines. New ones are being developed whilst others that already exist may be undergoing minor or major revisions. The remainder are in current use.
NICE has accredited the process used by BSR to produce its clinical guidance. Accreditation is valid for 5 years from February 2013.
For full details on our accreditation, visit nice.org.uk/accreditation
|New guidelines in development ||Due for publication |
|Management of SLE |
|Q2 2016 |
|Management of Scleroderma |
|Q1 2016 |
|Prescribing for rheumatological conditions in pregnancy and breastfeeding |
Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.
Part II: analgesics and other drugs used in rheumatology practice.
|Q4 2015 |
|Ankylosing spondylitis/spondyloarthropathies and biologics ||Q1 2016 |
|Management of Sjögren’s Syndrome || |